Literature DB >> 14578320

Improved HPLC method for carbohydrate-deficient transferrin in serum.

Anders Helander1, Asgeir Husa, Jan-Olof Jeppsson.   

Abstract

BACKGROUND: There is need for a reference method for transferrin glycoforms in serum to which routine immunologic methods for the alcohol marker carbohydrate-deficient transferrin (CDT) can be traceable. We describe an improved HPLC method for transferrin glycoforms.
METHODS: Transferrin was iron-saturated by mixing the serum with ferric nitrilotriacetic acid, and lipoproteins were precipitated with dextran sulfate and calcium chloride. Separation of glycoforms was performed on a SOURCE 15Q anion-exchange column using salt gradient elution. Quantification relied on selective absorbance of the iron-transferrin complex at 470 nm. The relative amount of each glycoform was calculated as a percentage of the area under the curve, using baseline integration.
RESULTS: The HPLC system provided reproducible separation and quantification of the asialo-, monosialo-, disialo-, trisialo-, tetrasialo-, pentasialo-, and hexasialotransferrin glycoforms. Most importantly, disialo- and trisialotransferrin were almost baseline separated. The intra- and interassay CV for disialotransferrin were <5%. Serum and the pretreated samples were stable for at least 2 days at 22 or 4 degrees C. Sera from 132 healthy controls contained [mean (SD)] 1.16 (0.25)% disialotransferrin, 4.77 (1.36)% trisialotransferrin, 80.18 (2.01)% tetrasialotransferrin, and 13.88 (1.69)% pentasialo- + hexasialotransferrin. In some cases of a high (>6%) trisialotransferrin, monosialotransferrin was detected at <0.25%. Asialotransferrin was not detected in control sera, but was detected in 57% of chronic heavy drinkers and in 62% of sera with >/=2% disialotransferrin.
CONCLUSIONS: The HPLC method fulfills the requirements of a preliminary reference method for CDT and should work for any combination of serum transferrin glycoforms. This method could also be useful for confirming positive CDT results by immunoassays in medico-legal cases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14578320     DOI: 10.1373/clinchem.2003.023341

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  17 in total

1.  Sensitivity and specificity of urinary ethyl glucuronide and ethyl sulfate in liver disease patients.

Authors:  Scott H Stewart; David G Koch; Douglas M Burgess; Ira R Willner; Adrian Reuben
Journal:  Alcohol Clin Exp Res       Date:  2012-06-22       Impact factor: 3.455

2.  Two Argentinean Siblings with CDG-Ix: A Novel Type of Congenital Disorder of Glycosylation?

Authors:  M B Bistué Millón; M A Delgado; N B Azar; N Guelbert; L Sturiale; D Garozzo; G Matthijs; J Jaeken; Raquel Dodelson de Kremer; C G Asteggiano
Journal:  JIMD Rep       Date:  2011-06-22

3.  Validation of blood phosphatidylethanol as an alcohol consumption biomarker in patients with chronic liver disease.

Authors:  Scott H Stewart; David G Koch; Ira R Willner; Raymond F Anton; Adrian Reuben
Journal:  Alcohol Clin Exp Res       Date:  2014-05-21       Impact factor: 3.455

4.  Genetic predisposition to fetal alcohol syndrome: association with congenital disorders of N-glycosylation.

Authors:  María E de la Morena-Barrio; María J Ballesta-Martínez; Raquel López-Gálvez; Ana I Antón; Vanessa López-González; Laia Martínez-Ribot; José Padilla; Antonia Miñano; Oscar García-Algar; Miguel Del Campo; Javier Corral; Encarna Guillén-Navarro; Vicente Vicente
Journal:  Pediatr Res       Date:  2017-09-20       Impact factor: 3.756

5.  Advanced gestational age increases serum carbohydrate-deficient transferrin levels in abstinent pregnant women.

Authors:  Ludmila N Bakhireva; Sandra Cano; William F Rayburn; Renate D Savich; Lawrence Leeman; Raymond F Anton; Daniel D Savage
Journal:  Alcohol Alcohol       Date:  2012-08-08       Impact factor: 2.826

6.  Liver disease and HPLC quantification of disialotransferrin for heavy alcohol use: a case series.

Authors:  Scott H Stewart; Susana Comte-Walters; Emily Bowen; Raymond F Anton
Journal:  Alcohol Clin Exp Res       Date:  2010-11       Impact factor: 3.455

7.  Relationship of Abnormal Chromatographic Pattern for Carbohydrate-Deficient Transferrin with Severe Liver Disease.

Authors:  Scott H Stewart; Adrian Reuben; Raymond F Anton
Journal:  Alcohol Alcohol       Date:  2016-10-07       Impact factor: 2.826

8.  Comparison of transferrin isoform analysis by capillary electrophoresis and HPLC for screening congenital disorders of glycosylation.

Authors:  Mihika B Dave; Alpa J Dherai; Vrajesh P Udani; Anaita U Hegde; Neelu A Desai; Tester F Ashavaid
Journal:  J Clin Lab Anal       Date:  2017-02-25       Impact factor: 2.352

9.  Biomarker testing to estimate under-reported heavy alcohol consumption by persons with HIV initiating ART in Uganda.

Authors:  Judith A Hahn; Mwebesa B Bwana; Martin A Javors; Jeffrey N Martin; Nneka I Emenyonu; David R Bangsberg
Journal:  AIDS Behav       Date:  2010-12

10.  Efficacy of Gabapentin for the Treatment of Alcohol Use Disorder in Patients With Alcohol Withdrawal Symptoms: A Randomized Clinical Trial.

Authors:  Raymond F Anton; Patricia Latham; Konstantin Voronin; Sarah Book; Michaela Hoffman; James Prisciandaro; Emily Bristol
Journal:  JAMA Intern Med       Date:  2020-05-01       Impact factor: 21.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.